{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T09:05:22Z","timestamp":1777712722313,"version":"3.51.4"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Most parotid metastases have been reported to come from the head and neck; however, cases metastasized from the lung are extremely rare. Missed diagnoses and misdiagnoses occurred quite a few times. Thus, accurately identifying the clinical features of parotid metastasis of lung cancer is important. However, current studies about this issue are mostly case reports, and little is known about the detailed and systematic aspects. We reported three cases of parotid metastases from lung cancer and then systematically searched similar cases through \u201cPub-Med\u201d and \u201cWeb of Science\u201d. Finally, twenty-three patients were included in the study. Eighty-three percent of which were males, and 19 patients were over 50 years old. In all cases wit<jats:underline>h<\/jats:underline> smoking history mentioned, 93% were smokers. The predominant pathological type was small cell lung cancer (SCLC, 13 patients, 56%). Seventeen combined with other site metastasis, while more than half of which were brain metastases. The survival time ranged from 3months-17years, and as for SCLCs, it was only 3months-40months. It can be concluded that clinical features, such as sex, age, smoking history, pathological types, and metastasis patterns, could provide valuable evidence for diagnosis. The lung seems to be the most common primary site of parotid metastases except for head and neck tumors. The two circumstances, SCLC coexisting with Warthin\u2019s tumor and parotid small cell carcinoma with lung metastasis, should be differentiated from parotid metastasis of lung cancer with caution For cases presented as SCLC, more aggressive strategies, such as chemotherapy with immunotherapy and maintenance therapy, may be more suitable. Due to the greater tendency of brain metastasis in such diseases, whole-brain radiation therapy, stereotactic radiosurgery or prophylactic cranial irradiation should be applied to corresponding patients in time. Additionally, lung cancer parotid metastases may be a marker of poor prognosis.<\/jats:p>","DOI":"10.3389\/fonc.2022.963094","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T12:05:24Z","timestamp":1661429124000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Parotid metastases from primary lung cancer: Case series and systematic review of the features"],"prefix":"10.3389","volume":"12","author":[{"given":"Rulan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00292-019-00677-8","article-title":"[Histology, cytology and molecular diagnostics of lung cancer]","volume":"40","author":"Mairinger","year":"2019","journal-title":"Pathologe"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01074","article-title":"Update on the biology, management, and treatment of small cell lung cancer (SCLC)","volume":"10","author":"Saltos","year":"2020","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0193","article-title":"Prolonging survival: The role of immune checkpoint inhibitors in the treatment of extensive-stage small cell lung cancer","volume":"25","author":"Melosky","year":"2020","journal-title":"Oncologist"},{"key":"B5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1440-1673.2004.01253.x","article-title":"Parotid gland as an initial site of metastasis","volume":"48","author":"MF","year":"2004","journal-title":"Australas Radiol 2004"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/dc.24629","article-title":"Secondary malignant tumors of the parotid gland: not a secondary problem","volume":"22","author":"Pastore","year":"2017","journal-title":"J BUON"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/dc.24629","article-title":"FNA diagnostics of secondary malignancies in the salivary gland: Bi-institutional experience of 36 cases","volume":"49","author":"Horakova","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.31729\/jnma.4898","article-title":"Histopathologic profile of salivary gland tumors among specimens from a tertiary care hospital: A descriptive cross-sectional study","volume":"58","author":"Ghartimagar","year":"2020","journal-title":"JNMA J Nepal Med Assoc"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s004050100314","article-title":"Metastasis of lung adenocarcinoma to parotid lymph node as initial clinical manifestation","volume":"258","author":"Imauchi","year":"2001","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4066\/AMJ.2016.2626","article-title":"Bilateral parotid involvement as the solitary metastatic site from squamous cell lung cancer","volume":"9","author":"Kumar","year":"2016","journal-title":"Australas Med J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-826220","article-title":"[The interesting case \u2013 case no. 68. metastasis of a small-cell bronchial carcinoma to the parotid gland]","volume":"84","author":"Boeger","year":"2005","journal-title":"Laryngorhinootologie"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/0278-2391(89)90014-1","article-title":"Bilateral parotid gland metastasis as the initial presentation of a small cell lung carcinoma","volume":"47","author":"Cantera","year":"1989","journal-title":"J Oral Maxillofac Surg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519865645","article-title":"A case of metastasis of small cell lung cancer to the parotid gland: a case report and literature review","volume":"47","author":"Cui","year":"2019","journal-title":"J Int Med Res"},{"key":"B14","article-title":"[Long-term survival following multimodality treatment of metachronous metastases (parotid gland, adrenal gland, brain and mediastinal lymph node) after resection of non-small cell lung cancer; report of a case]","volume":"59","author":"Katsurago","year":"2006","journal-title":"Kyobu Geka"},{"key":"B15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4103\/0970-2113.209233","article-title":"Metastasis to parotid gland from primary bronchogenic carcinoma: A case letter","volume":"34","author":"Lawande","year":"2017","journal-title":"Lung India"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2015.09.002","article-title":"Metastases from the lung presenting as a parotid lump","volume":"54","author":"Lenouvel","year":"2016","journal-title":"Br J Oral Maxillofac Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/0278-2391(88)90225-X","article-title":"Parotid metastasis of small cell carcinoma of the lung causing facial nerve paralysis","volume":"46","author":"Shalowitz","year":"1988","journal-title":"J Oral Maxillofac Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1477-7819-12-119","article-title":"Parotid gland metastasis of lung cancer: a case report","volume":"12","author":"Shi","year":"2014","journal-title":"World J Surg Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0b013e3181d7f186","article-title":"Small cell lung cancer diagnosed with metastasis in parotid gland","volume":"21","author":"Ulubas","year":"2010","journal-title":"J Craniofac Surg"},{"key":"B20","article-title":"Parotid gland metastasis - an unusual presentation of adenocarcinoma of lung","volume":"24","author":"Debnath","year":"2015","journal-title":"Mymensingh Med J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0709(98)90112-0","article-title":"Bilateral parotid gland metastases as the initial manifestation of a small cell carcinoma of the lung","volume":"19","author":"Hisa","year":"1998","journal-title":"Am J Otolaryngol"},{"key":"B22","article-title":"[Metastasis of small cell lung cancer to the parotid gland as the initial clinical manifestation, followed by metastases to the pituitary gland and lumber spinal cord]","volume":"36","author":"Takatsugi","year":"1998","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/dc.24428","article-title":"Intraparotid metastasis from lung adenocarcinoma diagnosed by FNAC-report of a rare case","volume":"48","author":"Stephen","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.14201\/orl.19886","article-title":"Parotid metastasis of small cell lung carcinoma. case report","volume":"11","author":"Sanchez-Legaza","year":"2020","journal-title":"Rev ORL"},{"key":"B25","article-title":"Metachronous, solitary parotid gland metastasis of primary lung adenocarcinoma: a misdiagnosed case report and literature review","volume":"10","author":"Yang","year":"2017","journal-title":"Int J OF Clin AND Exp Med"},{"key":"B26","article-title":"Parotid gland and cerebellum metastasis of lung cancer: a case report","volume":"9","author":"Wang","year":"2016","journal-title":"Int J Clin Exp Pathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4103\/jhnps.jhnps_10_20","article-title":"Non-small cell lung cancer presenting as parotid and scalp swellings: A rare clinical presentation","volume":"8","author":"Sankalp Singh","year":"2020","journal-title":"J Head Neck Physicians Surgeons"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.07.1429","article-title":"Oligometastatic lung adenocarcinoma with parotid gland metastasis","volume":"160","author":"Irons","year":"2021","journal-title":"Chest"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-246779","article-title":"Parotid gland metastasis of lung adenocarcinoma identified on surveillance (18)F-FDG PET\/CT","volume":"15","author":"Soputro","year":"2022","journal-title":"BMJ Case Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2015.09.010","article-title":"Parotid gland metastases of distant primary tumours: A diagnostic challenge","volume":"43","author":"Franzen","year":"2016","journal-title":"Auris Nasus Larynx"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-021-01901-3","article-title":"Symptoms and signs of parotid tumors and their value for diagnosis and prognosis: a 20-year review at a single institution","volume":"26","author":"Inaka","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","article-title":"Lung cancer 2020: Epidemiology, etiology, and prevention","volume":"41","author":"Bade","year":"2020","journal-title":"Clin Chest Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jmri.27061","article-title":"Multiparametric magnetic resonance imaging for the diagnosis and differential diagnosis of parotid gland tumors","volume":"52","author":"Gokce","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/cncy.21798","article-title":"FNA biopsy of secondary nonlymphomatous malignancies in salivary glands: A multi-institutional study of 184 cases","volume":"125","author":"Wang","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"B35","article-title":"Metastasis to parotid gland from non head and neck tumors","volume":"23","author":"Emanuelli","year":"2018","journal-title":"J BUON"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.3390\/diagnostics11112065","article-title":"Proliferation PET\/CT imaging of salivary gland tumor","volume":"11","author":"Minamimoto","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2014.11.019","article-title":"Warthin's tumour: Aetiopathogenesis dilemma, ten years of our experience","volume":"43","author":"Orabona","year":"2015","journal-title":"J Craniomaxillofac Surg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/07357907.2014.979365","article-title":"Warthin's tumors and their relationship to lung cancer","volume":"33","author":"White","year":"2015","journal-title":"Cancer Invest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2010.71.5.47915","article-title":"Parotid incidentaloma detected during thoracic PET imaging: how should these lesions be managed","volume":"71","author":"Thomas","year":"2010","journal-title":"Br J Hosp Med (Lond)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.10.116","article-title":"Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer","volume":"23","author":"Lardinois","year":"2005","journal-title":"J Clin Oncol"},{"key":"B41","article-title":"Multiple neoplasms of the salivary gland and the lung","volume":"39","author":"Arora","year":"1997","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-019-01049-7","article-title":"Incidence of non-salivary gland neoplasms in patients with warthin tumor: A study of 73 cases","volume":"14","author":"Zaccarini","year":"2020","journal-title":"Head Neck Pathol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2017.04.003","article-title":"Comprehensive analysis of parotid mass: A retrospective study of 369 cases","volume":"45","author":"Comoglu","year":"2018","journal-title":"Auris Nasus Larynx"},{"key":"B44","doi-asserted-by":"publisher","first-page":"20190420","DOI":"10.1259\/dmfr.20190420","article-title":"The histogram analysis of apparent diffusion coefficient in differential diagnosis of parotid tumor","volume":"49","author":"Chen","year":"2020","journal-title":"Dentomaxillofac Radiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clinimag.2021.09.005","article-title":"Parotid warthin's tumor: novel MR imaging score as diagnostic indicator","volume":"81","author":"Luna","year":"2022","journal-title":"Clin Imaging"},{"key":"B46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12880-021-00724-y","article-title":"Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging in the differential diagnosis of parotid tumors","volume":"21","author":"Xiang","year":"2021","journal-title":"BMC Med Imaging"},{"key":"B47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijom.2012.10.004","article-title":"Small cell carcinoma of the salivary gland: a systematic literature review and two case reports","volume":"42","author":"Servato","year":"2013","journal-title":"Int J Oral Maxillofac Surg"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/lary.25923","article-title":"Predictors of survival in parotid small cell carcinoma: A study of 344 cases","volume":"126","author":"Zhan","year":"2016","journal-title":"Laryngoscope"},{"key":"B49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12105-018-0896-4","article-title":"Proceedings of the NASHNP companion meeting, march 18th, 2018, Vancouver, BC, Canada: Salivary neuroendocrine carcinoma-an overview of a rare disease with an emphasis on determining tumor origin","volume":"12","author":"Chernock","year":"2018","journal-title":"Head Neck Pathol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.5858\/2001-125-0228-IFTTFA","article-title":"Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas","volume":"125","author":"Cheuk","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N Engl J Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.3390\/cancers12092522","article-title":"Immunotherapy in small cell lung cancer","volume":"12","author":"Esposito","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.05.002","article-title":"Phase II study of maintenance pembrolizumab in patients with extensive-stage small cell lung cancer (SCLC)","volume":"13","author":"Gadgeel","year":"2018","journal-title":"J Thorac Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1073274820932004","DOI":"10.1177\/1073274820932004","article-title":"S-1 maintenance therapy in extensive stage small-cell lung cancer-a randomized clinical study","volume":"27","author":"Nie","year":"2020","journal-title":"Cancer Control"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.06.011","article-title":"Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial","volume":"134","author":"Santo","year":"2019","journal-title":"Lung Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.04.001","article-title":"Efficacy and safety of niraparib as maintenance treatment in patients with extensive-stage SCLC after first-line chemotherapy: A randomized, double-blind, phase 3 study","volume":"16","author":"Ai","year":"2021","journal-title":"J Thorac Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-018-2764-8","article-title":"Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study","volume":"145","author":"Yan","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2011.535","article-title":"Application of conditional probability analysis to distant metastases from lung cancer","volume":"3","author":"Oikawa","year":"2012","journal-title":"Oncol Lett"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.568568","article-title":"Best supportive care versus whole-brain irradiation, chemotherapy alone, or WBRT plus chemotherapy in patients with brain metastases from small-cell lung cancer: A case-controlled analysis","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13014-020-01509-3","article-title":"Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study","volume":"15","author":"Ni","year":"2020","journal-title":"Radiat Oncol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdab106","article-title":"Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies","volume":"3","author":"Myall","year":"2021","journal-title":"Neurooncol Adv"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.1271","article-title":"Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: The FIRE-SCLC cohort study","volume":"6","author":"Rusthoven","year":"2020","journal-title":"JAMA Oncol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.08.016","article-title":"Prophylactic cranial irradiation (PCI) versus active MRI surveillance for small cell lung cancer: The case for equipoise","volume":"12","author":"Rusthoven","year":"2017","journal-title":"J Thorac Oncol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2017.026765","article-title":"Prophylactic cranial irradiation for extensive small-cell lung cancer","volume":"13","author":"Schild","year":"2017","journal-title":"J Oncol Pract"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.otc.2015.10.007","article-title":"Parotidectomy for parotid cancer","volume":"49","author":"Cracchiolo","year":"2016","journal-title":"Otolaryngol Clin North Am"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2006.05.010","article-title":"Metastatic disease to the parotid gland","volume":"135","author":"Nuyens","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-018-5154-6","article-title":"Management of the facial nerve in parotid cancer: preservation or resection and reconstruction","volume":"275","author":"Guntinas-Lichius","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.963094\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T12:05:30Z","timestamp":1661429130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.963094\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":68,"alternative-id":["10.3389\/fonc.2022.963094"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.963094","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"article-number":"963094"}}